ELAN
Price
$10.35
Change
-$0.15 (-1.43%)
Updated
Apr 1 closing price
Capitalization
7.87B
41 days until earnings call
PCRX
Price
$24.04
Change
-$0.81 (-3.26%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
1.36B
28 days until earnings call
Ad is loading...

ELAN vs PCRX

Header iconELAN vs PCRX Comparison
Open Charts ELAN vs PCRXBanner chart's image
Elanco Animal Health
Price$10.35
Change-$0.15 (-1.43%)
Volume$3.49M
Capitalization7.87B
Pacira BioSciences
Price$24.04
Change-$0.81 (-3.26%)
Volume$4.11K
Capitalization1.36B
ELAN vs PCRX Comparison Chart
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. PCRX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a StrongBuy and PCRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ELAN: $10.35 vs. PCRX: $24.85)
Brand notoriety: ELAN: Notable vs. PCRX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 74% vs. PCRX: 70%
Market capitalization -- ELAN: $7.87B vs. PCRX: $1.36B
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. PCRX’s [@Pharmaceuticals: Other] market capitalization is $1.36B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whilePCRX’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • PCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCRX is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 5 TA indicator(s) are bullish while PCRX’s TA Score has 6 bullish TA indicator(s).

  • ELAN’s TA Score: 5 bullish, 3 bearish.
  • PCRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ELAN and PCRX are a good buy in the short-term.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а -1.52% price change this week, while PCRX (@Pharmaceuticals: Other) price change was +0.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was -2.49%, and the average quarterly price growth was +49.72%.

Reported Earning Dates

ELAN is expected to report earnings on May 13, 2025.

PCRX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than PCRX($1.36B). PCRX YTD gains are higher at: 31.900 vs. ELAN (-14.533). PCRX has higher annual earnings (EBITDA): 155M vs. ELAN (-224M). ELAN has more cash in the bank: 352M vs. PCRX (279M). PCRX has less debt than ELAN: PCRX (586M) vs ELAN (5.77B). ELAN has higher revenues than PCRX: ELAN (4.42B) vs PCRX (675M).
ELANPCRXELAN / PCRX
Capitalization7.87B1.36B581%
EBITDA-224M155M-145%
Gain YTD-14.53331.900-46%
P/E RatioN/A32.74-
Revenue4.42B675M654%
Total Cash352M279M126%
Total Debt5.77B586M985%
FUNDAMENTALS RATINGS
ELAN vs PCRX: Fundamental Ratings
ELAN
PCRX
OUTLOOK RATING
1..100
189
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8393
PRICE GROWTH RATING
1..100
8140
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCRX's Valuation (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (90) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew somewhat faster than ELAN’s over the last 12 months.

PCRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (83) in the Agricultural Commodities Or Milling industry is in the same range as PCRX (93) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PCRX’s over the last 12 months.

PCRX's Price Growth Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (81) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew somewhat faster than ELAN’s over the last 12 months.

ELAN's P/E Growth Rating (96) in the Agricultural Commodities Or Milling industry is in the same range as PCRX (100) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANPCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
64%
Bullish Trend 9 days ago
71%
Declines
ODDS (%)
Bearish Trend 12 days ago
74%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AMAX7.460.05
+0.69%
Adaptive Hedged Multi-Asset Income ETF
BSCW20.420.05
+0.25%
Invesco BulletShares 2032 Corp Bd ETF
FTCS89.690.05
+0.06%
First Trust Capital Strength ETF
KWT35.66N/A
N/A
iShares® MSCI Kuwait ETF
SABA8.69-0.01
-0.11%
Saba Capital Income & Opportunities Fund II

PCRX and

Correlation & Price change

A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
-0.24%
ELAN - PCRX
32%
Poorly correlated
+0.86%
TEVA - PCRX
28%
Poorly correlated
+1.92%
ACET - PCRX
27%
Poorly correlated
-9.06%
SNDL - PCRX
26%
Poorly correlated
-2.76%
NBIX - PCRX
25%
Poorly correlated
-2.26%
More